Agile Therapeutics Announces Virtual Investor/Analyst Day on Monday, September 21, 2020
September 08 2020 - 8:00AM
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare
company, today announced that it will host a virtual
Investor/Analyst Day on Monday, September 21, 2020 from 11:00 AM to
1:00 PM EDT.
Members of the Agile Therapeutics senior management team and an
industry key opinion leader will provide an overview of the Twirla®
commercial program, including planned launch activities, marketing
initiatives and managed care strategy.
Scheduled speakers include:
- Al Altomari, Agile Therapeutics Chairman and
Chief Executive Officer
- Dennis Reilly, Agile Therapeutics Senior Vice
President and Chief Financial Officer
- Kimberly Whelan, Agile Therapeutics Vice
President of Sales and Market Access
- Amy Welsh, Agile Therapeutics Vice President
of Marketing
- Dr. David Portman, MD, FACOG, OB/GYN and Agile
Therapeutics Consultant
Those interested in attending can click the RSVP
link in the Events & Presentations page of the ‘Investors’
section of the Agile Therapeutics website or by clicking
here.
A live audio webcast of the presentation with
accompanying slides can be accessed by visiting
ir.agiletherapeutics.com/events-and-presentations. Please log in
approximately 10 minutes prior to the scheduled start time. The
archived webcast will be available in the Events and Presentations
section of the Company's website for 30 days.
About Agile Therapeutics,
Inc.Agile Therapeutics is a women's healthcare
company dedicated to fulfilling the unmet health needs of today’s
women. Our product candidates are designed to provide women with
contraceptive options that offer freedom from taking a daily pill,
without committing to a longer-acting method. Our initial product,
Twirla®, (levonorgestrel and ethinyl estradiol) transdermal system
is a non-daily prescription contraceptive. Twirla is based on our
proprietary transdermal patch technology, called Skinfusion®, which
is designed to allow drug delivery through the skin. For more
information, please visit the company website
at www.agiletherapeutics.com. The Company may
occasionally disseminate material, nonpublic information on the
Company’s website.
Follow Agile on LinkedIn and
Twitter: @AgileTher.
Contact: Matt RileyHead
of Investor Relations & Corporate
Communicationsmriley@agiletherapeutics.com
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Apr 2024 to May 2024
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From May 2023 to May 2024